Artiva Biotherapeutics ARTV
NASDAQ ARTV
$7.12 +0.09 (+1.28%)
At close: Sep 30, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Receivables - Other (2023 - 2026)

Updated

Artiva Biotherapeutics (ARTV) recorded Receivables - Other of $141,000 in Q2 2026, up 370.0% from $30,000 a year earlier.

Analysis

Artiva Biotherapeutics (ARTV) Receivables - Other (2023 - 2026) Analysis & Trends

At the end of FY2025, Artiva Biotherapeutics reported Receivables - Other of $67,000, down 54.1% from FY2024.

  • Across earlier years, Receivables - Other came in at $146,000 in FY2024 (-79.8%) and $724,000 in FY2023.
  • The Q2 2026 figure is the highest quarterly Receivables - Other since Q1 2025.
  • On a year-over-year basis, Receivables - Other rose in 1 of the last five quarters, with growth averaging 19.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Artiva Biotherapeutics 280.62 Mn 280.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 141,000.00
Dec 31, 2025 67,000.00
Sep 30, 2025 79,000.00
Jun 30, 2025 30,000.00
Mar 31, 2025 234,000.00
Dec 31, 2024 146,000.00
Sep 30, 2024 132,000.00
Jun 30, 2024 892,000.00
Dec 31, 2023 724,000.00
API Access

Artiva Biotherapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ARTV&period=max&api_key=YOUR_API_KEY